Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 9.0B | 7.5B | 7.4B | 6.9B |
Cost of revenue | 6.6B | 2.6B | 2.0B | 4.8B |
Gross profit | 2.4B | 4.9B | 5.4B | 2.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 94.8M | 65.1M | 79.0M | 82.0M |
Other operating expenses | — | 731.3M | 746.3M | — |
Operating income | 4.5B | 4.1B | 4.6B | 3.6B |
Non operating interest income | ||||
Income | — | — | 409.7M | 492.8M |
Expense | — | — | 255.4M | 259.7M |
Other income expense | 2.1B | -986K | -199.0M | -135.4M |
Pretax income | 5.3B | 5.0B | 4.5B | 3.7B |
Tax provision | 1.7B | 1.5B | 1.3B | 1.1B |
Net income | 3.6B | 3.5B | 3.2B | 2.6B |
Basic EPS | — | 11.3 | 10.3 | 8.5 |
Diluted EPS | — | 11.3 | 10.3 | 8.5 |
Basic average shares | — | 300.0M | 300.0M | 300.0M |
Diluted average shares | — | 300.0M | 300.0M | 300.0M |
EBITDA | 8.8B | 4.7B | 5.5B | 4.7B |
Net income from continuing op. | 5.3B | 5.0B | 4.5B | 3.7B |
Minority interests | -175.1M | -93.4M | -104.7M | -80.0M |
Preferred stock dividends | — | — | — | — |